California Public Employees Retirement System Cel Sci Corp Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$8.68 - $27.49 $596,316 - $1.89 Million	-68,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$12.0 - $27.64 $31,332 - $72,168	-2,611 Reduced 3.66%	68,700 $1.05 Million
Q4 2020 Feb 02, 2021	SELL	$11.05 - $16.62 $84,189 - $126,627	-7,619 Reduced 9.65%	71,311 $831,000
Q3 2020 Nov 05, 2020	BUY	$11.69 - $14.54 $42,084 - $52,344	3,600 Added 4.78%	78,930 $1.01 Million
Q2 2020 Aug 12, 2020	BUY	$9.75 - $17.6 $269,636 - $486,728	27,655 Added 58.01%	75,330 $1.12 Million
Q4 2019 Jan 27, 2020	BUY	$6.71 - $9.55 $319,899 - $455,296	47,675 New	47,675 $436,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account